JP2004041218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004041218A5 JP2004041218A5 JP2003293651A JP2003293651A JP2004041218A5 JP 2004041218 A5 JP2004041218 A5 JP 2004041218A5 JP 2003293651 A JP2003293651 A JP 2003293651A JP 2003293651 A JP2003293651 A JP 2003293651A JP 2004041218 A5 JP2004041218 A5 JP 2004041218A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- amino acid
- nucleotide sequence
- mitogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 42
- 229920001184 polypeptide Polymers 0.000 claims description 41
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 26
- 210000003027 ear inner Anatomy 0.000 claims description 12
- 239000003226 mitogen Substances 0.000 claims description 12
- 230000035755 proliferation Effects 0.000 claims description 7
- 210000002266 hair cells auditory Anatomy 0.000 claims description 3
- 206010011878 Deafness Diseases 0.000 claims description 2
- 230000010370 hearing loss Effects 0.000 claims description 2
- 231100000888 hearing loss Toxicity 0.000 claims description 2
- 208000016354 hearing loss disease Diseases 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims 32
- 102000039446 nucleic acids Human genes 0.000 claims 32
- 150000007523 nucleic acids Chemical class 0.000 claims 32
- 125000003275 alpha amino acid group Chemical group 0.000 claims 17
- 239000002773 nucleotide Substances 0.000 claims 15
- 125000003729 nucleotide group Chemical group 0.000 claims 15
- 210000002950 fibroblast Anatomy 0.000 claims 11
- 230000004663 cell proliferation Effects 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 5
- 108091026890 Coding region Proteins 0.000 claims 4
- 238000007792 addition Methods 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 230000037430 deletion Effects 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
- 238000003556 assay Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000000185 follicular epithelial cell Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11285198P | 1998-12-16 | 1998-12-16 | |
| US11314598P | 1998-12-16 | 1998-12-16 | |
| US11351198P | 1998-12-22 | 1998-12-22 | |
| US11556599P | 1999-01-12 | 1999-01-12 | |
| US11555899P | 1999-01-12 | 1999-01-12 | |
| US11573399P | 1999-01-12 | 1999-01-12 | |
| US11934199P | 1999-02-09 | 1999-02-09 | |
| US11953799P | 1999-02-10 | 1999-02-10 | |
| US11996599P | 1999-02-12 | 1999-02-12 | |
| PCT/US1999/012252 WO1999063088A2 (en) | 1998-06-02 | 1999-06-02 | Membrane-bound proteins and nucleic acids encoding the same |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Division JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004041218A JP2004041218A (ja) | 2004-02-12 |
| JP2004041218A5 true JP2004041218A5 (enExample) | 2007-04-05 |
Family
ID=27578476
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Withdrawn JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2003293651A Withdrawn JP2004041218A (ja) | 1998-12-16 | 2003-08-14 | 分泌ポリペプチドとそれをコードする核酸 |
| JP2003293650A Withdrawn JP2004041217A (ja) | 1998-12-16 | 2003-08-14 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2006282251A Withdrawn JP2007075118A (ja) | 1998-12-16 | 2006-10-17 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2007156006A Withdrawn JP2007312779A (ja) | 1998-12-16 | 2007-06-13 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Withdrawn JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003293650A Withdrawn JP2004041217A (ja) | 1998-12-16 | 2003-08-14 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2006282251A Withdrawn JP2007075118A (ja) | 1998-12-16 | 2006-10-17 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2007156006A Withdrawn JP2007312779A (ja) | 1998-12-16 | 2007-06-13 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1141285A2 (enExample) |
| JP (5) | JP2003521229A (enExample) |
| KR (2) | KR100468978B1 (enExample) |
| AU (7) | AU777006B2 (enExample) |
| CA (1) | CA2348757A1 (enExample) |
| IL (11) | IL142794A0 (enExample) |
| MX (1) | MXPA01006057A (enExample) |
| WO (1) | WO2000036102A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US6914130B2 (en) * | 1998-06-17 | 2005-07-05 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| ATE500328T1 (de) | 1999-03-11 | 2011-03-15 | Merck Serono Sa | Vaskuläre adhesionsmoleküle und modulierung ihrer funktion |
| AU2008201101B2 (en) * | 1999-03-11 | 2011-01-20 | Merck Serono Sa | Vascular adhesion molecules and modulation of their function |
| KR100543857B1 (ko) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
| DE19947010A1 (de) * | 1999-09-30 | 2001-04-05 | Universitaetsklinikum Freiburg | Das Gen PRV-1 und dessen Verwendung |
| AU2001259191A1 (en) * | 2000-04-28 | 2001-11-12 | Millennium Pharmaceuticals, Inc. | 25692, a novel human o-methyltransferase family member and uses thereof |
| GB0110273D0 (en) * | 2001-04-26 | 2001-06-20 | Inpharmatica Ltd | Novel proteins |
| CA2470900A1 (en) * | 2001-12-19 | 2003-07-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20070191402A1 (en) * | 2002-05-17 | 2007-08-16 | Kyowa Hakko Kogyo Co., Ltd. | Method of searching substrate having antidiabetic activity |
| US20050283842A1 (en) * | 2002-10-02 | 2005-12-22 | Karsten Eulenberg | Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| PT2500030E (pt) | 2005-11-04 | 2015-09-24 | Genentech Inc | Uso de inibidores da via do complemento para tratar doenças oculares |
| JP2010504955A (ja) | 2006-09-28 | 2010-02-18 | メルク セローノ ソシエテ アノニム | 接合部接着分子ｃ（ｊａｍ−ｃ）結合化合物とその利用方法 |
| PL2907827T3 (pl) | 2006-11-02 | 2019-03-29 | Genentech, Inc. | Humanizowane przeciwciała przeciw czynnikowi D i ich zastosowanie |
| AR066660A1 (es) | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| WO2009137605A2 (en) | 2008-05-06 | 2009-11-12 | Genentech, Inc. | AFFINITY MATURED CRIg VARIANTS |
| CR20160132A (es) | 2013-08-12 | 2016-08-25 | Genentech Inc | Composiciones y método para tratar condiciones asociadas con el complemento |
| KR20160147855A (ko) | 2014-05-01 | 2016-12-23 | 제넨테크, 인크. | 항-인자 d 항체 변이체 및 이의 용도 |
| HK1257422A1 (zh) | 2015-10-30 | 2019-10-18 | 豪夫迈‧罗氏有限公司 | 抗-因子d抗体变体缀合物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10508486A (ja) * | 1994-11-07 | 1998-08-25 | メルク エンド カンパニー インコーポレーテッド | 修飾神経ペプチドｙレセプター |
| AU1532697A (en) * | 1996-01-12 | 1997-08-01 | Genetics Institute Inc. | Beta-chemokine, h1305 (mcp-2) |
| JP2001515361A (ja) * | 1997-05-06 | 2001-09-18 | ザイモジェネティクス，インコーポレイティド | 新規な腫瘍抗原 |
| DE19818620A1 (de) * | 1998-04-21 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Blase-Normal |
| WO2000000610A2 (en) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
| WO2000004135A2 (en) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Human scad-related molecules, scrm-1 and scrm-2 |
| DE19849044A1 (de) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | Das Gen PRV-1 und dessen Verwendung |
| EP1131428A2 (en) * | 1998-11-19 | 2001-09-12 | Incyte Pharmaceuticals, Inc. | Immunoglobulin superfamily proteins |
| ES2289630T3 (es) * | 1999-03-08 | 2008-02-01 | Genentech, Inc. | Composiciones y procedimientos para el diagnostico de tumores. |
-
1999
- 1999-12-01 WO PCT/US1999/028634 patent/WO2000036102A2/en not_active Ceased
- 1999-12-01 EP EP99962992A patent/EP1141285A2/en not_active Withdrawn
- 1999-12-01 KR KR10-2001-7007461A patent/KR100468978B1/ko not_active Expired - Fee Related
- 1999-12-01 CA CA002348757A patent/CA2348757A1/en not_active Abandoned
- 1999-12-01 KR KR10-2004-7013508A patent/KR100468977B1/ko not_active Expired - Fee Related
- 1999-12-01 AU AU19320/00A patent/AU777006B2/en not_active Expired
- 1999-12-01 MX MXPA01006057A patent/MXPA01006057A/es active IP Right Grant
- 1999-12-01 JP JP2000588351A patent/JP2003521229A/ja not_active Withdrawn
- 1999-12-01 IL IL14279499A patent/IL142794A0/xx active IP Right Grant
-
2001
- 2001-04-25 IL IL142794A patent/IL142794A/en not_active IP Right Cessation
-
2003
- 2003-08-14 JP JP2003293651A patent/JP2004041218A/ja not_active Withdrawn
- 2003-08-14 JP JP2003293650A patent/JP2004041217A/ja not_active Withdrawn
-
2004
- 2004-12-10 AU AU2004237842A patent/AU2004237842B2/en not_active Expired
- 2004-12-14 AU AU2004237920A patent/AU2004237920B2/en not_active Expired
- 2004-12-14 AU AU2004237919A patent/AU2004237919B2/en not_active Expired
- 2004-12-14 AU AU2004237923A patent/AU2004237923B2/en not_active Expired
- 2004-12-14 AU AU2004237922A patent/AU2004237922B2/en not_active Expired
- 2004-12-14 AU AU2004237921A patent/AU2004237921B2/en not_active Expired
-
2006
- 2006-10-17 JP JP2006282251A patent/JP2007075118A/ja not_active Withdrawn
-
2007
- 2007-06-13 JP JP2007156006A patent/JP2007312779A/ja not_active Withdrawn
-
2008
- 2008-01-03 IL IL188577A patent/IL188577A0/en unknown
- 2008-01-03 IL IL188579A patent/IL188579A0/en unknown
- 2008-01-03 IL IL188578A patent/IL188578A0/en unknown
- 2008-01-03 IL IL188576A patent/IL188576A0/en unknown
- 2008-01-03 IL IL188580A patent/IL188580A0/en unknown
- 2008-01-03 IL IL188581A patent/IL188581A0/en unknown
-
2009
- 2009-09-13 IL IL200883A patent/IL200883A0/en unknown
- 2009-09-17 IL IL201030A patent/IL201030A0/en unknown
- 2009-09-17 IL IL201001A patent/IL201001A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003532365A5 (enExample) | ||
| JP2005516613A5 (enExample) | ||
| JP2005046146A5 (enExample) | ||
| WO1991018101A1 (en) | Process for producing protein | |
| WO2025241381A1 (zh) | 一种能表达外源蛋白的菌株、重组人源胶原蛋白及合成方法与应用 | |
| RU2007124369A (ru) | Производство белков | |
| JP2637393B2 (ja) | プロインシュリンおよびプレプロインシュリン産生暗号を有するヒト遺伝子 | |
| RU2230116C2 (ru) | ВЕКТОР ДЛЯ ЭКСПРЕСИИ И СЕКРЕЦИИ ЧЕЛОВЕЧЕСКОГО ИНТЕРФЕРОНА АЛЬФА(HIFNα), ШТАММ ESCHERICHIA COLI ДЛЯ ЭКСПРЕССИИ И СЕКРЕЦИИ HIFNα(ВАРИАНТЫ) И СПОСОБ ПРОДУЦИРОВАНИЯ HIFNα | |
| WO1997008312B1 (en) | Human jtv1 gene overlaps pms2 gene | |
| US9845475B2 (en) | Expression vector | |
| JP2000504561A (ja) | Ｉｌ―１６活性のあるポリペプチド類、その製造方法およびその使用 | |
| CN115992103A (zh) | 酶突变体及类蛇毒三肽的制备方法 | |
| JP2003530821A5 (enExample) | ||
| JPS6037990A (ja) | Ｇｒｆ前駆体をコードするｄｎａ | |
| WO2000020439A1 (fr) | Procede d'elimination de methionine n-terminale | |
| JP7800891B2 (ja) | タンパク質生成に対するキメラシグナルペプチド | |
| WO1986003779A1 (fr) | Vecteur de secretion de polypeptides, micro-organismes transformes par ledit vecteur, et procede de preparation de polypeptides avec lesdits micro-organismes | |
| JP2004512009A5 (enExample) | ||
| WO2020133610A1 (zh) | 一种重组大肠杆菌质周腔内生产唾液酸修饰n-糖基化重组蛋白方法 | |
| US5304471A (en) | Process for producing foreign protein in Escherichia coli | |
| JP2662044B2 (ja) | Ｄｎａ配列、発現ベクターおよびポリペプチドの周辺質生産方法 | |
| CN101985466A (zh) | Mbd重组蛋白及其表达方法 | |
| JP2001509390A (ja) | コイルドコイル構造を含む融合タンパク質 | |
| JP2005527194A5 (enExample) | ||
| US20060177845A1 (en) | UBP1 protease mutant, and its coding sequence, their application and methods of production |